Arrowhead Pharma
(ARWR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2025 | 09-2024 | 09-2023 | 09-2022 | 09-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 226,548 | 102,685 | 110,891 | 108,005 | 184,434 |
| Marketable Securities | 692,818 | 578,276 | 292,735 | 268,391 | 183,355 |
| Receivables | 6,824 | N/A | N/A | 1,410 | 10,255 |
| Other current assets | 13,516 | 4,973 | 4,033 | 20,204 | 2,191 |
| TOTAL | $950,639 | $695,471 | $416,472 | $405,299 | $384,597 |
| Non-Current Assets | |||||
| PPE Net | 382,515 | 386,032 | 290,262 | 110,297 | 48,675 |
| Investments And Advances | 0 | 0 | 0 | 105,872 | 245,595 |
| Intangibles | 6,861 | 8,562 | 10,262 | 11,962 | 13,663 |
| Other Non-Current Assets | 45,280 | 49,737 | 48,556 | 58,509 | 17,618 |
| TOTAL | $434,656 | $444,331 | $349,080 | $286,640 | $325,551 |
| Total Assets | $1,385,295 | $1,139,802 | $765,552 | $691,939 | $710,148 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 40,000 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 17,674 | 11,388 | 35,866 | 2,868 | 9,457 |
| Accrued Expenses | 117,314 | 85,006 | 57,726 | 59,107 | 23,774 |
| Other current liabilities | 10,811 | 432 | 435 | N/A | N/A |
| TOTAL | $195,487 | $103,168 | $105,456 | $138,850 | $146,536 |
| Non-Current Liabilities | |||||
| Long Term Debt | 214,883 | 393,183 | N/A | N/A | N/A |
| Deferred Revenues | 2,399 | N/A | 866 | 74,099 | 111,055 |
| Other Non-Current Liabilities | 439,764 | 462,588 | 376,934 | 79,231 | 23,295 |
| TOTAL | $686,392 | $845,571 | $372,934 | $134,750 | $154,790 |
| Total Liabilities | $881,879 | $948,739 | $478,390 | $273,600 | $301,326 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 135,810 | 124,434 | 107,432 | 106,006 | 104,526 |
| Common Shares | 231 | 217 | 200 | 198 | 197 |
| Retained earnings | -1,627,154 | -1,625,523 | -1,026,030 | -820,755 | -644,692 |
| Other shareholders' equity | 43,614 | 10,369 | 12,597 | 19,683 | -69 |
| TOTAL | $503,416 | $191,063 | $287,162 | $418,339 | $408,822 |
| Total Liabilities And Equity | $1,385,295 | $1,139,802 | $765,552 | $691,939 | $710,148 |